Pharmaron Beijing Co., Ltd. (SHE: 300759)
China
· Delayed Price · Currency is CNY 25.21
+0.36 (1.45%)
Feb 5, 2025, 3:04 PM CST
Pharmaron Beijing Revenue
Pharmaron Beijing had revenue of 3.21B CNY in the quarter ending September 30, 2024, with 10.02% growth. This brings the company's revenue in the last twelve months to 11.80B, up 3.25% year-over-year. In the year 2023, Pharmaron Beijing had annual revenue of 11.54B with 12.39% growth.
Revenue (ttm)
11.80B
Revenue Growth
+3.25%
P/S Ratio
3.79
Revenue / Employee
581.18K
Employees
20,295
Market Cap
41.21B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 11.54B | 1.27B | 12.39% |
| Jan 1, 2023 | 10.27B | 2.82B | 37.92% |
| Dec 31, 2021 | 7.44B | 2.31B | 45.00% |
| Dec 31, 2020 | 5.13B | 1.38B | 36.64% |
| Dec 31, 2019 | 3.76B | 849.04M | 29.20% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 26.00B |
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| WuXi AppTec | 38.50B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
| Aier Eye Hospital Group | 20.62B |
| Yunnan Baiyao Group Co.,Ltd | 39.34B |
| Shanghai United Imaging Healthcare | 10.93B |
| Beijing Wantai Biological Pharmacy Enterprise | 2.49B |